Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: BuySellSignals Research
$5.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Ranbaxy Laboratories Ltd To Pay $500 Million In US Settlement-Reuters


Monday, 13 May 2013 05:39pm EDT 

Reuters reported that Ranbaxy Laboratories Ltd pleaded guilty to felony charges related to drug safety and will pay $500 million in civil and criminal fines under the settlement agreement with the U.S. Department of Justice. It includes $150 million in payments for a criminal fine and forfeiture and $350 million in payments for civil claims. 

Company Quote

553.7
-2.45 -0.44%
6:14am EDT